A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
Zachary A. Knight(Howard Hughes Medical Institute), Kevan M. Shokat(Howard Hughes Medical Institute), Roger Williams(MRC Laboratory of Molecular Biology), Morri E. Feldman(Howard Hughes Medical Institute), András Balla(Semmelweis University), Eli R. Zunder(Howard Hughes Medical Institute), Tamás Balla(Eunice Kennedy Shriver National Institute of Child Health and Human Development), David Goldenberg(Pennsylvania State University), William A. Weiss(City College of San Francisco), David Stokoe(Enzo Life Sciences (United States)), Balázs István Tóth(Kaiser Permanente South San Francisco Medical Center), Robbie Loewith(University of Geneva), Olusegun Williams(Howard Hughes Medical Institute), Beatriz González(MRC Laboratory of Molecular Biology)
Cited by 1,151
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k